# BORUZU

NDC: 70121-2484
Generic name: Bortezomib
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20240927

FDA application: NDA212782

## Active ingredients

- BORTEZOMIB: 3.5 mg/1.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-2484"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-2484
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b92628dd-fa09-4c3a-b6a3-66426025807c